0.51 (-%)
As of Nov 20, 2024
Source:
Passage Bio, Inc. is a clinical stage genetic medicines company focused on developing transformative therapies for CNS disorders. Our vision is to finally fulfill the promise of gene therapy by developing groundbreaking therapies that transform the lives of patients with CNS diseases.
| Country | United States |
| Headquarters | philadelphia, pennsylvania |
| Phone Number | 2678660312 |
| Industry | manufacturing |
| CEO | William Chou, M.D. |
| Website | www.clinicaltrials.gov |